Stay up to date
We are moving fast and shaping the cell & gene landscape requires a lot of engagement amongst all stakeholders in the ecosystem.
We keep you informed about the latest news on Tigen and we would be delighted to get your feedback and your point of view.
Lausanne, 10 September 2023
Tigen and ELCA collaborate on digital solutions to accelerate the development and supply of T cell-based cancer therapies. ELCA was awarded Microsoft Partner of the Year 2023, also based on our collaboration to advance digital healthcare.
Paris, 1 June 2023
The International Society for Cell & Gene Therapy (ISCT) Paris 2023 conference was full of new insights and great conversations that led to many new contacts in the CGT ecosystem. Tigen's Ursula Busse presented our work on Next Generation TIL Therapies run together with CHUV and Ludwig Institute for Cancer Research.
Lausanne, 31 May 2023
We discovered some new sights of Lausanne last evening. The B2Run Schweizer Firmenlauf gathered an energetic crowd of athletes from small to large companies in the Stade de Pierre de Coubertin.
Boston, 31 May 2023
Therese Choquette from the Tigen analytics team is sharing insights from our development work at the 2nd Cell Therapy Potency Assay Summit in Boston from May 31 - June 2, 2023.
We are curious to discuss with and learn from the CGT analytics community during the pre-conference workshop.